Lonza to Acquire Codiak’s Exosomes Manufacturing Facility And Establish; Codiak To Receive ~$65M Of In-Kind Manufacturing Services For Its Clinical-Stage Programs And Retain Core Exosome Engineering And Loading Expertise

by | Nov 2, 2021 | Uncategorized | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.